CONCORD BIOTECH share price has zoomed 7% and is presently trading at Rs 2,117.3.
Meanwhile, the BSE HEALTHCARE index is at 44,741.0 (up 0.2%).
Among the top gainers in the BSE HEALTHCARE index today are Pfizer (up 2.2%) and ALKEM LABORATORIES (up 1.3%).
Torrent Pharma (down 0.9%) and ALEMBIC PHARMA (down 0.9%) are among the top losers today.
Over the last one year, CONCORD BIOTECH has moved up from Rs 1,189.8 to Rs 2,117.3, registering a gain of Rs 927.5 (up 78.0%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,166.2 to 44,741.0, registering a gain of 58.8% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 200.3%), Glenmark Pharma (up 122.6%) and SUVEN PHARMACEUTICALS (up 114.1%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 81,526.2 .
The top gainers among the BSE Sensex today are L&T (up 1.1%) and Infosys (up 1.1%). The most traded stocks in the BSE Sensex are Tata Steel and SBI.
In the meantime, NSE Nifty is at 24,940.2 (down 0.1%). Bajaj Auto and Hero Motocorp are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 66,166.9 to 81,526.2, registering a gain of 15,359.3 points (up 23.2%).
CONCORD BIOTECH net profit grew 20.2% YoY to Rs 582 million for the quarter ended June 2024, compared to a profit of Rs 485 million a year ago. Net sales rose 10.8% to Rs 2,158 million during the period as against Rs 1,948 million in April-June 2023.
For the year ended March 2024, CONCORD BIOTECH reported 28.3% increase in net profit to Rs 3,081 million compared to net profit of Rs 2,401 million during FY23. Revenue of the company grew 19.2% to Rs 10,169 million during FY24.
The current Price to earnings ratio of CONCORD BIOTECH, based on rolling 12 month earnings, stands at 70.4.
Equitymaster requests your view! Post a comment on "CONCORD BIOTECH Gains 7%; BSE HEALTHCARE Index Up 0.2%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!